What is the optimal prostate-specific antigen cutoff to determine the success of prostate cancer treatment?
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
What is the optimal prostate-specific antigen cutoff to determine the success of prostate cancer treatment?
Melanoma treatment mystery gets new answers
New study suggests genomic newborn screening could identify some children at risk for early cancers
Liver cancer experts co-author new treatment framework for hepatocellular carcinoma
Study uncovers pre-cancerous link between air pollution exposure and lung cancer risk
Can mini organs help predict breast tumours’ response to therapy
Trk and IGF1R-related signaling linked to delayed Ewing sarcoma growth
Study finds traditional prostate cancer risk factors do not predict hormone therapy benefit
Researchers identify an 'energy addiction' in high-risk blood cancer stem cells
Where women live may influence ovarian cancer survival, especially among Black women
Immune cells in bone marrow cancer: limited defense readiness
Biomarkers aid cost-benefit analysis of head and neck cancer immunotherapy